Mitochondrial Dynamic Proteins MiD49 and MiD51 as Novel Targets of Cardioprotection
Cells · 2026
DOI: 10.3390/cells15060559 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Parisa Samangouei und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Hatter Cardiovascular Institute, Institute of Cardiovascular Science, University College London, London WC1E 6HX, UK. Hauptthemen laut MEDLINE: Mitochondrial Dynamics, Mitochondrial Proteins, Cardiotonic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Singapore Ministry of Health's National Medical Research Council, CADENCE National Clinical Translational Program.
Abstract (Originalsprache)
Novel therapeutic strategies are required to protect the heart from acute ischaemia-reperfusion injury (IRI) and improve outcomes in patients with acute myocardial infarction (AMI). Mitochondria play a critical role in determining cardiomyocyte fate following acute IRI, with genetic and pharmacological inhibition of Drp1-mediated mitochondrial fission limiting cardiomyocyte death. We investigated the role of the mitochondrial Drp1 receptors, MiD49 and MiD51, as novel targets for cardioprotection. In cardiac cell lines subjected to simulated IRI, dual genetic knockdown of both MiD49 and MiD51 reduced cell death, inhibited mitochondrial fission, prevented mitochondrial permeability transition pore opening, and attenuated mitochondrial calcium overload compared with wild-type cells. However, individual knockdown of either MiD49 or MiD51 did not induce mitochondrial elongation or inhibit MPTP opening. Whole-body genetic ablation of MiD49 in adult mice modestly altered mitochondrial morphology but did not affect myocardial infarct size or cardiac function following AMI. Together with the in vitro protection seen with dual MiD49/51 knockdown, these findings suggest that MiD49 deficiency alone is insufficient and that coordinated inhibition of MiD49 and MiD51 may be required for cardioprotection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Hatter Cardiovascular Institute, Institute of Cardiovascular Science, University College London, London WC1E 6HX, UK.
- National Heart Research Institute Singapore, National Heart Centre, Singapore 16909, Singapore.
- Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.
- La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3083, Australia.
- Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.
- Yong Loo Lin School of Medicine, National University Singapore, Singapore 117597, Singapore.
ORCID-Profile: Parisa Samangouei, Gustavo E Crespo-Avilan, Xiu-Yi Kwek, Derek M Yellon
Förderung
- British Heart Foundation
- Singapore Ministry of Health's National Medical Research Council
- CADENCE National Clinical Translational Program
- A*STAR
Zitieren
APA
Samangouei, P., Crespo-Avilan, G. E., Hall, A. R., Hernandez-Resendiz, S., Elder, J. M., Osellame, L. D., Tee, N. G. Z., Katwadi, K., Ong, S. B., Kwek, X. Y., Beikoghli Kalkhoran, S., Burke, N., Yellon, D. M., & Hausenloy, D. J. (2026). Mitochondrial Dynamic Proteins MiD49 and MiD51 as Novel Targets of Cardioprotection. Cells. https://doi.org/10.3390/cells15060559
Vancouver
Samangouei P, Crespo-Avilan GE, Hall AR, Hernandez-Resendiz S, Elder JM, Osellame LD, et al. Mitochondrial Dynamic Proteins MiD49 and MiD51 as Novel Targets of Cardioprotection. Cells. 2026. doi:10.3390/cells15060559
BibTeX
@article{Samangouei2026,
author = {Samangouei, Parisa and Crespo-Avilan, Gustavo E and Hall, Andrew R and Hernandez-Resendiz, Sauri and Elder, J Maeve and Osellame, Laura D and Tee, Nicole G Z and Katwadi, Khairunnisa and Ong, Sang-Bing and Kwek, Xiu-Yi and Beikoghli Kalkhoran, Siavash and Burke, Niall and Yellon, Derek M and Hausenloy, Derek J},
title = {Mitochondrial Dynamic Proteins MiD49 and MiD51 as Novel Targets of Cardioprotection},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15060559}
}
EUVIMED